Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yan-Ruide Li

Showing results (41-50 of 92) with videos related to

Pageof 10
Sort By:
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2024
Managing allorejection in off-the-shelf CAR-engineered cell therapiesYan-Ruide Li, Ying Fang, Siyue Niu, et al.
ACS Nano|April 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer TherapyCitradewi Soemardy, Yan-Ruide Li, Yichen Zhu, et al.
Cell Stem Cell|March 22, 2023
Advancing cell-based cancer immunotherapy through stem cell engineeringYan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Journal of Biomedical Science|January 4, 2026
Microbiome modulation of tumorigenesis and immune responsesYuning Chen, Ying Fang, Zibai Lyu, et al.
Leukemia|March 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemiaYan-Ruide Li, Xinyuan Shen, Yuning Chen, et al.
Frontiers in Medicine|April 17, 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapyYuning Chen, Yichen Zhu, Adam Kramer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2022
Mucosal-associated invariant T cells for cancer immunotherapyYan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy Oncolytics|October 25, 2023
Advancements in CRISPR screens for the development of cancer immunotherapy strategiesYan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Cells|May 14, 2022
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer ImmunotherapyYan-Ruide Li, Yanqi Yu, Adam Kramer, et al.
Oncotarget|September 15, 2017
Myosin Va plays essential roles in maintaining normal mitosis, enhancing tumor cell motility and viabilityYan-Ruide Li, Ai Zhong, Han Dong, et al.
Pageof 10

Showing results (41-50 of 92) with videos related to

Sort By:
Pageof 10
Molecular Therapy : the Journal of the American Society of Gene Therapy|November 27, 2024
Managing allorejection in off-the-shelf CAR-engineered cell therapiesYan-Ruide Li, Ying Fang, Siyue Niu, et al.
ACS Nano|April 16, 2026
Universal Nanovial Screening Enables Functional Discovery of Metabolite-Reactive T-Cell Receptors for Cancer TherapyCitradewi Soemardy, Yan-Ruide Li, Yichen Zhu, et al.
Cell Stem Cell|March 22, 2023
Advancing cell-based cancer immunotherapy through stem cell engineeringYan-Ruide Li, Zachary Spencer Dunn, Yanqi Yu, et al.
Journal of Biomedical Science|January 4, 2026
Microbiome modulation of tumorigenesis and immune responsesYuning Chen, Ying Fang, Zibai Lyu, et al.
Leukemia|March 27, 2026
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemiaYan-Ruide Li, Xinyuan Shen, Yuning Chen, et al.
Frontiers in Medicine|April 17, 2023
Genetic engineering strategies to enhance antitumor reactivity and reduce alloreactivity for allogeneic cell-based cancer therapyYuning Chen, Yichen Zhu, Adam Kramer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|December 4, 2022
Mucosal-associated invariant T cells for cancer immunotherapyYan-Ruide Li, Kuangyi Zhou, Matthew Wilson, et al.
Molecular Therapy Oncolytics|October 25, 2023
Advancements in CRISPR screens for the development of cancer immunotherapy strategiesYan-Ruide Li, Zibai Lyu, Yanxin Tian, et al.
Cells|May 14, 2022
An Ex Vivo 3D Tumor Microenvironment-Mimicry Culture to Study TAM Modulation of Cancer ImmunotherapyYan-Ruide Li, Yanqi Yu, Adam Kramer, et al.
Oncotarget|September 15, 2017
Myosin Va plays essential roles in maintaining normal mitosis, enhancing tumor cell motility and viabilityYan-Ruide Li, Ai Zhong, Han Dong, et al.
Pageof 10